Brad Briggs is the Editorial Director of StreetAuthority. A veteran of the financial publishing industry, Brad manages the team of writers and editors responsible for our premium newsletters, free newsletters, and website. He formerly co-wrote our Maximum Profit premium newsletter, and is also the managing editor for StreetAuthority's premium subscribers-only newsletter, StreetAuthority Insider.
Brad bought his first stock in high school and has been hooked ever since. After graduating early from college, success in the market enabled him to pay off his student loans and buy his first house. Brad believes that successful investing doesn't have to be complicated, and that anyone can achieve financial independence no matter their background. One of his proudest accomplishments is holding on to Apple since 2014.
As Editorial Director, Brad makes it his mission to demystify the world of investing for a wide audience. His writing has been featured in outlets like Yahoo Finance, Nasdaq.com, and MSN Money, among others.
When he's not following the market, Brad spends his time powerlifting and tending to cattle near his home in Texas.
Analyst Articles
Anyone can get lucky once in a while. The same goes for the so-called “experts” on Wall Street. But when the overwhelming majority of experts agree on a handful of stocks, investors should take notice. When a stock has, say, 20 analysts covering it — and all 20 think the… Read More
They say success comes at a price. The same thing applies to capital gains. Most investors forgot that lesson in the 1990s, when high-growth “dot-com” stocks were all the rage. Growth at any price was the name of the game, and some investors paid dearly for it. Read More
Every company has a life cycle. Some, like Microsoft (Nasdaq: MSFT) or Google (Nasdaq: GOOG), seemingly come out of nowhere to dominate their industries. Others, like Consolidated Edison (NYSE: ED) or General Electric (NYSE: GE), have delivered steady returns to shareholders for decades. But let’s face it:… Read More
When procrastinating husbands open their wallets to pay for decadent Valentine’s Day chocolate, they’re likely to wind up paying a little more than usual this year. They can thank the growing worldwide sugar shortage for that. Read More
Big Pharma needs some big ideas. If it can’t find them — and turn them into the next blockbuster drugs — then it will be in Big Trouble. The clock is always ticking for the nation’s drug makers. That’s because drug patents last only 20 years. The… Read More
Everyone likes a good list to start a new year. Whether it’s a “Top 10” of this or a “Best of” that, it’s always a fun exercise. But when it comes to picking stocks, nothing is as easy as it looks. If you’re an investor looking for… Read More
Governments like to print money. It’s one of the immutable laws of the universe. Like gravity, or the certainty that Johnson & Johnson (NYSE: JNJ) will pay a dividend next quarter. Paper money can be traced back to the year 960. Read More
Never judge a stock by its share price. Just because a stock trades for $5 does not make it “cheap.” Conversely, a stock that trades for $100 is not necessarily “expensive.” Millions of investors ignore this. Mention a stock and the first question out of most investors’… Read More
Beginning next Wednesday and for the following two weeks Copenhagen will have the coal industry on pins and needles. That’s where President Barack Obama and leaders of 190 other countries will convene to try to reach a consensus on reducing carbon emissions. It’s doubtful that the international… Read More
Emerging markets have been the success story of 2009. While more developed economies such as the United States and Europe have struggled to recover, countries like Brazil, Russia, India and China are on a roll. Country (… Read More
